China Universal Asset Management Co., Ltd. Protagonist Therapeutics, Inc Transaction History
China Universal Asset Management Co., Ltd.
- $773 Million
- Q1 2024
A detailed history of China Universal Asset Management Co., Ltd. transactions in Protagonist Therapeutics, Inc stock. As of the latest transaction made, China Universal Asset Management Co., Ltd. holds 11,192 shares of PTGX stock, worth $377,394. This represents 0.04% of its overall portfolio holdings.
Number of Shares
11,192
Previous 11,192
-0.0%
Holding current value
$377,394
Previous $324,000
0.31%
% of portfolio
0.04%
Previous 0.04%
Shares
12 transactions
Others Institutions Holding PTGX
# of Institutions
187Shares Held
59.5MCall Options Held
35.7KPut Options Held
72.3K-
Farallon Capital Management LLC San Francisco, CA5.74MShares$194 Million0.77% of portfolio
-
Black Rock Inc. New York, NY5.57MShares$188 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY5.32MShares$179 Million2.47% of portfolio
-
Bvf Inc San Francisco, CA3.76MShares$127 Million3.25% of portfolio
-
State Street Corp Boston, MA3.27MShares$110 Million0.0% of portfolio
About Protagonist Therapeutics, Inc
- Ticker PTGX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 49,084,100
- Market Cap $1.66B
- Description
- Protagonist Therapeutics, Inc., a biopharmaceutical company, discovers and develops peptide-based therapeutic drugs to address hematology and blood disorders, and inflammatory and immunomodulatory diseases. It is developing rusfertide (PTG-300), an injectable hepcidin mimetic that is in Phase II clinical trials for the treatment of patients with...